**Abstract**

**Objective:** MSCs that have been isolated from different sources are expected to possess different secretion patterns which might influence the therapeutic mechanism in the disease environment.

**Introduction:** Through their paracrine effects such as immunomodulation and trophic functions, mesenchymal stem cells (MSCs) have been reported to possess the therapeutic potential to be used as a viable treatment for various diseases. MSCs can be isolated from different sources including adipose tissue, bone marrow, placenta and Wharton's Jelly(WJ), and be expanded *in vitro*. Although they possess similar characteristics, the source of origin of the MSCs is thought to affect the overall secretion patterns and thus their applications in the disease environment.

**Methods:** MSCs from different sources (adipose, bone marrow, placenta, WJ) were cultured in serum free MEM-α medium for 24 hours at 37°C 5% CO~2~. The collected media were mixed with protease inhibitors and were then concentrated up to 250-fold. The concentrated media was then mixed with lysis buffer consisting of 8M urea, 75mM NaCl, and 50mM Tris (pH 8.2). The protein mixtures were digested into peptide samples and were then scanned under LC-MS/MS. Secreted proteins that were identified were functionally analyzed by DAVID.

**Results:** The features and patterns of secreted proteins were highly dependent on the source of the MSC. While a majority of the secreted proteins of MSCs from neonatal sources (placenta, WJ) was highly involved in the developmental process, secreted proteins of MSCs from adult sources (adipose, bone marrow) were related to biological regulation and metabolic process.

**Conclusion:** This study shows that source difference is an aspect that needs to be considered for disease-specific mesenchymal stem cell therapeutics and personalized therapy of neurodegenerative diseases.
